Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
175 hedge funds and large institutions have $659M invested in Meridian Bioscience Inc in 2015 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 60 increasing their positions, 60 reducing their positions, and 16 closing their positions.
44% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 16
4% more funds holding
Funds holding: 168 → 175 (+7)
0% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 60
8% less capital invested
Capital invested by funds: $716M → $659M (-$56.9M)
49% less call options, than puts
Call options by funds: $1.47M | Put options by funds: $2.87M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$18.7M |
| 2 |
ICOM
Investment Counselors of Maryland
Baltimore,
Maryland
|
+$4.39M |
| 3 |
JP Morgan Chase
New York
|
+$4.31M |
| 4 |
Renaissance Technologies
New York
|
+$3.41M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Cortland Advisers
Wilmington,
Delaware
|
-$19.6M |
| 2 |
Neuberger Berman Group
New York
|
-$6.05M |
| 3 |
PP
Prudential plc
London, England,
United Kingdom
|
-$5.45M |
| 4 |
CPCM
Clifton Park Capital Management
Wilmington,
Delaware
|
-$5.39M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.4M |
VIVO Hedge Fund Activity: Q3 2015 in Review
175 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2015, worth a combined $659M — down 7.9% from $716M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new VIVO positions and 16 closed out — a net gain of 7 holders — while 60 added to existing stakes and 60 trimmed.
The largest buyer was Brown Capital Management, adding an estimated $18.7M. The largest seller was Cortland Advisers, exiting entirely with an estimated $19.6M sold.
- 175 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2015, up from 168 in Q2 2015.
- Funds reported $659M of Meridian Bioscience Inc stock for Q3 2015, down 7.9% quarter-over-quarter.
- 23 funds opened new Meridian Bioscience Inc positions in Q3 2015 and 16 closed out, a net change of +7 holders.
- The largest Meridian Bioscience Inc buyer in Q3 2015 was Brown Capital Management, an estimated $18.7M added.
- The largest Meridian Bioscience Inc seller in Q3 2015 was Cortland Advisers, an estimated $19.6M sold.
Based on aggregated 13F filings for Q3 2015.